A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population

(2015) Eva-Maria Zitzmann-Roth et al.   PLoS One

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis

(2015) Richard N Greenberg et al.   PLoS One

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis

(2014) Frank von Sonnenburg et al.   VACCINE

Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals

(2014) Sharon E. Frey et al.   VACCINE

Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial

(2013) Stephen R. Walsh et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

(2013) Sharon E. Frey et al.   VACCINE

Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects

(2012) R. N. Greenberg et al.   JOURNAL OF INFECTIOUS DISEASES

Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain

(2009) Mark Suter et al.   VACCINE

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE® against aerosolized rabbitpox virus in a rabbit model

(2009) Nicole L. Garza et al.   VACCINE

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

(2009) Alfred von Krempelhuber et al.   VACCINE

Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study

(2008) Dennis D. Taub et al.   AMERICAN JOURNAL OF MEDICINE

Smallpox vaccines for biodefense: need and feasibility

(2008) Andrew W Artenstein et al.   Expert Review of Vaccines

Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection

(2008) Christofer Samuelsson et al.   JOURNAL OF CLINICAL INVESTIGATION

Can the Immune System Still Be Efficient in the Elderly? An Immunological and Immunoendocrine Therapeutic Perspective

(2008) Gerald Pfister et al.   NEUROIMMUNOMODULATION